Home Cart Sign in  
Chemical Structure| 1350636-82-6 Chemical Structure| 1350636-82-6

Structure of Lefamulin acetate
CAS No.: 1350636-82-6

Chemical Structure| 1350636-82-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Lefamulin acetate is an orally active antibiotic. It inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome. Additionally, Lefamulin acetate possesses anti-inflammatory activity and can be used to study bacterial infections, such as bacterial pneumonia.

Synonyms: BC-3781 acetate; Xenleta; Lefamulin(acetate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Lefamulin acetate

CAS No. :1350636-82-6
Formula : C30H49NO7S
M.W : 567.78
SMILES Code : O=C(O[C@H]1[C@@]([C@H](C)CC2)(C)[C@@](C(CC3)=O)([H])[C@]32[C@@H](C)[C@H](O)[C@](C)(C=C)C1)CS[C@H]4[C@H](O)C[C@H](N)CC4.OC(C)=O
Synonyms :
BC-3781 acetate; Xenleta; Lefamulin(acetate)
MDL No. :MFCD28963990

Safety of Lefamulin acetate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Vancomycin-sensitive E. faecium (VSEfm) 16 μg/mL 16-18 hours Evaluate the susceptibility of VSEfm to lefamulin, showing resistance to lefamulin. Nat Commun. 2022 Apr 7;13(1):1888
Vancomycin-resistant Enterococcus faecium (VREfm) 0.03 μg/mL 16-18 hours Evaluate the susceptibility of VREfm to lefamulin, showing a significant increase in sensitivity to lefamulin. Nat Commun. 2022 Apr 7;13(1):1888
HCCLM3 SR cells 20 ×10^−6 M 48 hours Evaluate the inhibitory effect of lefamulin alone or combined with sorafenib on cell proliferation, results showed that combined treatment significantly inhibited cell proliferation. Adv Sci (Weinh). 2024 Aug;11(30):e2401789
HepG2 SR cells 10 ×10^−6 M 48 hours Evaluate the synergistic effect of lefamulin combined with sorafenib, results showed that combined treatment significantly inhibited cell growth and promoted apoptosis. Adv Sci (Weinh). 2024 Aug;11(30):e2401789
J774 mouse macrophages 1 or 5 mg/L 5 hours To evaluate the accumulation of lefamulin in macrophages, results showed rapid accumulation of lefamulin in macrophages, reaching intracellular concentrations of 35.6 mg/L (1 mg/L external concentration) and 218 mg/L (5 mg/L external concentration) after 1 hour, and 54.4 mg/L and 270 mg/L after 5 hours. J Antimicrob Chemother. 2019 Apr 1;74(Suppl 3):iii11-iii18
S. aureus cell-free transcription-translation system 0.02 μg/ml (IC50) 1 hour To evaluate the inhibitory effect of lefamulin on protein synthesis in S. aureus. Results showed that lefamulin has a lower IC50 value compared to other pleuromutilin antibiotics, indicating its stronger inhibitory capability. Sci Rep. 2016 Dec 13;6:39004
Staphylococcus aureus ribosome 44.9 μM (22.8 μg/ml) 6 hours To study the binding mode of lefamulin to the large ribosomal subunit of S. aureus and its mechanism of protein synthesis inhibition. Results showed that lefamulin binds to the PTC site, forming hydrogen bonds and hydrophobic interactions, thereby inhibiting protein synthesis. Sci Rep. 2016 Dec 13;6:39004
Vero cells <0.004–0.063 mg/L 28 days To evaluate the in vitro antimicrobial activity of lefamulin against Mycoplasma genitalium, results showed high susceptibility of all cultured isolates to lefamulin, with only one strain exhibiting an elevated MIC of 0.063 mg/L. J Antimicrob Chemother. 2025 Feb 3;80(2):465-471

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Intestinal colonization model and peritonitis-septicemia model Oral (intestinal colonization model), intraperitoneal injection (peritonitis-septicemia model) 5 mg/kg (intestinal colonization model), 10 mg/kg (peritonitis-septicemia model) Single dose (intestinal colonization model), every 24 hours (peritonitis-septicemia model) Evaluate the efficacy of lefamulin against VREfm in vivo, showing effective reduction in colonization and improved survival. Nat Commun. 2022 Apr 7;13(1):1888
Balb/c nude mice HCC xenograft model Intraperitoneal injection 25 or 50 mg/kg Daily Evaluate the inhibitory effect of lefamulin alone or combined with sorafenib on tumor growth, results showed that combined treatment significantly inhibited tumor growth and reduced tumor weight. Adv Sci (Weinh). 2024 Aug;11(30):e2401789
BALB/c mice Neutropenic pneumonia model Subcutaneous 1.25–160 mg/kg Twice daily for 24 hours To evaluate the pharmacodynamics of lefamulin in a neutropenic pneumonia model, results showed significant reduction in bacterial load correlated with AUC/MIC ratios. J Antimicrob Chemother. 2019 Apr 1;74(Suppl 3):iii11-iii18
ICR Swiss mice Neutropenic murine thigh infection model Subcutaneous 5 to 320 mg/kg Every 12 hours for 24 hours To evaluate the in vivo pharmacodynamics of lefamulin against five Streptococcus pneumoniae and five Staphylococcus aureus strains, finding that efficacy correlated most strongly with the AUC0–24/MIC ratio. J Antimicrob Chemother. 2019 Apr 1;74(Suppl 3):iii5-iii10
Mice LPS-induced inflammation model Subcutaneous injection 1, 10, 30, 100 mg/kg Single dose To evaluate the effect of Lefamulin acetate on total cells and neutrophils in LPS-induced inflammation model. Results showed that Lefamulin acetate significantly reduced the number of total cells and neutrophils in BALF. PLoS One. 2021 Sep 29;16(9):e0237659

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.81mL

1.76mL

0.88mL

17.61mL

3.52mL

1.76mL

 

Historical Records

Categories